3.44
+0.2033(+6.27%)
Currency In USD
Address
Rue du Centre 172
Rolle, 1025
Switzerland
Phone
41 21 694 10 60
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Employees
423
First IPO Date
July 23, 2021
| Name | Title | Pay | Year Born |
| Dr. Jurgi Camblong M.B.A., Ph.D. | Co-Founder, Chief Executive Officer & Director | 1.17M | 1979 |
| Mr. Ross Jordan Muken B.Sc. | President | 0 | 1981 |
| Dr. Philippe Menu M.B.A., M.D., Ph.D. | Executive Vice President, Chief Medical Officer & Chief Product Officer | 0 | 1982 |
| Mr. Kevin Puylaert | Vice President & MD of EMEA | 0 | N/A |
| Dr. Zhenyu Xu Ph.D. | Executive Vice President & Chief Scientific Officer | 0 | 1983 |
| Kellen Sanger | Head of Strategy and Investor Relations | 0 | N/A |
| Mr. Daan van Well L.L.M., M.B.A. | Executive Vice President, Chief Legal & Regulatory Officer | 0 | 1975 |
| Mr. George A. Cardoza M.B.A. | Executive Vice President & Chief Financial Officer | 0 | 1962 |
| Ms. Manuela Da Silva Valente B.A. | Executive Vice President & Chief People Officer | 0 | 1971 |
| Mr. Abhimanyu Verma | Senior Vice President & Chief Technology Officer | 0 | N/A |
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.